A carregar...
Selecting Patients at Risk of Developing DKA on Gliflozins
Background: Since the introduction of gliflozins less than a decade ago we have witnessed how these medications are changing our approach to treating patients with type 2 diabetes mellitus. While recognizing tremendous benefits from these medication we are aware of potentially fatal risks. We presen...
Na minha lista:
| Publicado no: | J Endocr Soc |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089501/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.811 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|